Beranda › Kanker Payudara › Illinois › Rockford
Uji klinis Kanker Payudara di Rockford, IL
5 studi untuk Kanker Payudara mencari peserta di lokasi sekitar Rockford (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- OSF Saint Anthony Medical Center, Rockford
- Mercyhealth Cancer Institute - Rockford, Rockford
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Menerima pesertaFase 3
- UW Health Carbone Cancer Center Rockford, Rockford
E-Mindfulness Approaches for Living After Breast Cancer
Menerima pesertaFase 3
- OSF Saint Anthony Medical Center, Rockford
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Menerima pesertaFase 3
- UW Health Carbone Cancer Center Rockford, Rockford
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- OSF Saint Anthony Medical Center, Rockford
Uji klinis Kanker Payudara di kota lain
- New York City, NY136 studi
- Houston, TX126 studi
- Boston, MA112 studi
- Nashville, TN81 studi
- Los Angeles, CA73 studi
- Edison, NJ68 studi
- St. Louis, MO64 studi
- Queens, NY64 studi
- Durham, NC64 studi
- Chicago, IL59 studi
- Philadelphia, PA56 studi
- Dallas, TX55 studi
Studi lain di Rockford
- Kanker Paru5 studi
- Kanker Paru Non-Sel Kecil4 studi
- Penyakit Ginjal Kronis3 studi
- Kanker Kolon3 studi
- Kanker Kolorektal3 studi
- Kanker Ginjal (Karsinoma Sel Renal)3 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.